1,721,073 research outputs found
La favorita. Splendon più belle / [Donizetti], comp. ; O. Luppi, B ; Coristi della Scala [acc orch]. Don Carlo. Dormirò sol / [Verdi], comp ; Oreste Luppi, B [acc p]
No full textTitre uniforme : Donizetti, Gaetano (1797-1848). Compositeur. [La favorite]. Extrait ; arr. (italien)Titre uniforme : Verdi, Giuseppe (1813-1901). Compositeur. [Don Carlos (1884)]. ExtraitComprend : La favorita / [Donizetti], comp. ; O. Luppi, B ; Coristi della Scala [acc orch] ; Don Carlo / [Verdi], comp ; Oreste Luppi, B [acc p]Contient une table des matière
Simon Boccanegra. Il lacerato spirito / [Verdi], comp. Mefistofele. Ecco il mondo / [Boito], comp ; Oresto Luppi, B [acc p]
No full textTitre uniforme : Verdi, Giuseppe (1813-1901). Compositeur. [Simon Boccanegra]. ExtraitTitre uniforme : Boito, Arrigo (1842-1918). Compositeur. [Mefistofele]. ExtraitComprend : Simon Boccanegra / [Verdi], comp ; Oresto Luppi, B [acc p] ; Mefistofele / [Boito], comp ; Oresto Luppi, B [acc p]Contient une table des matière
Behavioral Biases and the Law
No full textEmpirical and experimental evidence shows that individuals exhibit behavioral biases in their decision-making processes that depart from the full rationality paradigm. This paper discusses the effectiveness of alternative debiasing strategies, designed to induce socially preferable outcomes. Following Jolls, C. and Sunstein, C.R. (2006). Debiasing through law. J. Leg. Stud. 35: 199-242, this paper examines legal strategies that aim at "debiasing through law", attempting to reduce or eliminate boundedly rational behavior. Alternatively, policymakers can implement "insulating"legal strategies that separate the outcome from the biased behavior, without attempting to eradicate behavioral biases from the decision-making process. This paper compares these strategies in many areas, such as tort law, consumer safety law, and property law
Salvator Rosa. Di sposo... di padre / [Gomes], comp. Gli ugonotti. Dispersa sen vada : canzone ugonotta / Meyerbeer, comp ; Oresto Luppi, B (Marcello) [acc p]
No full textTitre uniforme : Gomes, Carlos (1836-1896). Compositeur. [Salvator Rosa]. ExtraitTitre uniforme : Meyerbeer, Giacomo (1791-1864). Compositeur. [Les Huguenots]. Extrait ; arr (italien)Comprend : Salvator Rosa / [Gomes], comp ; Oresto Luppi, B (Marcello) [acc p] ; Gli ugonotti / Meyerbeer, comp ; Oresto Luppi, B (Marcello) [acc p]Contient une table des matière
Economia comportamentale: limitazioni cognitive, preferenze socialmente condizionate e comportamento economico
No full textDrug "supersaturation" states induced by polymeric micelles and liposomes: A mechanistic investigation into permeability enhancements
No full textDevelopment of microparticles for oral administration of the non-conventional radical scavenger IAC and testing in an inflammatory rat model.
No full textDevelopment of microparticles for oral administration of the non-conventional radical scavenger
IAC and testing in an inflammatory rat model
1)Cirillo S.. 2)Paolini M.. 3)Vivarelli F.. 4)Passerini N.. 5)Albertini B.. 6)Di sabatino M. 7)Corace G.. 8)Luppi B..
9)Canistro D..
University of Bologna
The bis (1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl)-decandioate (IAC) is an innovative nonconventional
radical scavenger used with success in several disease models, such as inflammation,
neurological disorders, hepatitis and diabetes. To date, the main limit for the drug use is
represented by the intraperitoneal (i.p.) route of administration used in the pharmacological
treatments. In order to develop a delivery system that allowed both oral administration and the
therapeutic efficacy, Solid Lipid Microparticles (SLMs) containing a theoretical 18% w/w of IAC
have been produced. Recently, three formulations (A, B, C) have been tested at different dosages
in an inflammation and pain rat model. Inflammatory model was induced by the use of an
intraplantar injection of 100ml/paw of Freund's complete adjuvant (FCA). Administered per os at
different dosages, IAC B (60% stearic acid-20% Compritol® HD5 ATO) was the most efficient
formulation in reducing oedema and alleviating pain, compared to the gold standard Paracetamol.
Since the anti-diabetic effects of the i.p. formulation of IAC was already demonstrated in vivo, we
are now investigating the therapeutic efficacy of the selected (B) oral IAC formulation (SLMs) in
streptozotocin-nicotinamide diabetic mice
- …
